Insider · CIK 0001366244
Benjamin L Palleiko
ceoofficerdirector
Files at KALV (KalVista Pharmaceuticals, Inc.). First filing Nov 19, 2024, latest Sep 9, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 11
$0 bought, $1.4M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | KalVista Pharmaceuticals, Inc. | $116k 7,294 shares | -2% | - | |
| 36Weak | KalVista Pharmaceuticals, Inc. | $145k 10,940 shares | -3% | - | |
| 32Weak | KalVista Pharmaceuticals, Inc. | $58k 4,409 shares | -1% | - | |
| 51Moderate | KalVista Pharmaceuticals, Inc. | $518k 32,979 shares | -8% | - | |
| 20Weak | KALVsell KalVista Pharmaceuticals, Inc. | $104k 7,169 shares | -2% | - | |
| 35Weak | KalVista Pharmaceuticals, Inc. | $119k 9,999 shares | -3% | - | |
| 31Weak | KalVista Pharmaceuticals, Inc. | $45k 3,808 shares | -1% | - | |
| 34Weak | KalVista Pharmaceuticals, Inc. | $80k 6,669 shares | -2% | - | |
| 32Weak | KalVista Pharmaceuticals, Inc. | $50k 5,104 shares | -2% | - | |
| 33Weak | KalVista Pharmaceuticals, Inc. | $74k 7,627 shares | -3% | - | |
| 36Weak | KalVista Pharmaceuticals, Inc. | $133k 14,400 shares | -5% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 6, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +15,625 | - | - | 402,483 | Sep 9, 2025 |
| Sep 8, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -7,294 | $15.84 | $116k | 395,189 | Sep 9, 2025 |
| Sep 6, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -15,625 | $0.00 | $0 | 156,251 | Sep 9, 2025 |
| Aug 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +23,250 | - | - | 397,798 | Aug 25, 2025 |
| Aug 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -10,940 | $13.22 | $145k | 386,858 | Aug 25, 2025 |
| Aug 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -23,250 | $0.00 | $0 | 325,500 | Aug 25, 2025 |
| Aug 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +9,362 | - | - | 378,957 | Aug 19, 2025 |
| Aug 18, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -4,409 | $13.19 | $58k | 374,548 | Aug 19, 2025 |
| Aug 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -2,418 | $0.00 | $0 | 7,257 | Aug 19, 2025 |
| Aug 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -6,944 | $0.00 | $0 | 6,945 | Aug 19, 2025 |
| Aug 11, 2025 | KALV KalVista Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitderivative | +113,920 | $0.00 | $0 | 113,920 | Aug 13, 2025 |
| Aug 11, 2025 | KALV KalVista Pharmaceuticals, Inc. | AGrant or award Employee Stock Optionderivative | +113,920 | $0.00 | $0 | 113,920 | Aug 13, 2025 |
| Jul 8, 2025 | KALV KalVista Pharmaceuticals, Inc. | AGrant or award Common Stock | +87,500 | - | - | 402,574 | Jul 10, 2025 |
| Jul 9, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -32,979 | $15.69 | $518k | 369,595 | Jul 10, 2025 |
| Jun 6, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +15,625 | - | - | 322,243 | Jun 10, 2025 |
| Jun 9, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -7,169 | $14.50 | $104k | 315,074 | Jun 10, 2025 |
| Jun 6, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -15,625 | $0.00 | $0 | 171,876 | Jun 10, 2025 |
| May 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +23,250 | - | - | 316,617 | May 23, 2025 |
| May 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -9,999 | $11.88 | $119k | 306,618 | May 23, 2025 |
| May 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -23,250 | $0.00 | $0 | 348,750 | May 23, 2025 |
| May 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +9,364 | - | - | 297,175 | May 20, 2025 |
| May 19, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -3,808 | $11.84 | $45k | 293,367 | May 20, 2025 |
| May 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -2,419 | $0.00 | $0 | 9,675 | May 20, 2025 |
| May 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -6,945 | $0.00 | $0 | 13,889 | May 20, 2025 |
| Mar 6, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +15,625 | - | - | 294,480 | Mar 10, 2025 |
| Mar 7, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -6,669 | $11.97 | $80k | 287,811 | Mar 10, 2025 |
| Mar 6, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -15,625 | $0.00 | $0 | 187,501 | Mar 10, 2025 |
| Feb 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitderivative | +372,000 | $0.00 | $0 | 372,000 | Feb 25, 2025 |
| Feb 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +9,363 | - | - | 283,959 | Feb 19, 2025 |
| Feb 18, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -5,104 | $9.82 | $50k | 278,855 | Feb 19, 2025 |
| Feb 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -2,419 | $0.00 | $0 | 12,094 | Feb 19, 2025 |
| Feb 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -6,944 | $0.00 | $0 | 20,834 | Feb 19, 2025 |
| Dec 6, 2024 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +15,625 | - | - | 282,223 | Dec 9, 2024 |
| Dec 9, 2024 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -7,627 | $9.75 | $74k | 274,596 | Dec 9, 2024 |
| Dec 6, 2024 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -15,625 | $0.00 | $0 | 203,126 | Dec 9, 2024 |
| Nov 17, 2024 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +30,198 | - | - | 280,998 | Nov 19, 2024 |
| Nov 18, 2024 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -14,400 | $9.26 | $133k | 266,598 | Nov 19, 2024 |
| Nov 17, 2024 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -2,419 | $0.00 | $0 | 14,513 | Nov 19, 2024 |
| Nov 17, 2024 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -6,945 | $0.00 | $0 | 27,778 | Nov 19, 2024 |
| Nov 17, 2024 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Performance Stock Unitsderivative | -20,834 | $0.00 | $0 | 0 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.